Articles On Telix Pharmaceuticals (ASX:TLX)

Title Source Codes Date
3 ASX 200 shares I would buy before February

With February reporting season fast approaching, investors face a familiar decision. Do you wait for results and risk paying a higher price, or do you act early and accept the uncertainty that comes with buying ahead of updates? If I we...

Motley Fool TLX 4 months ago
Australian Equity Market Context Across ASX 200 and ASX 300

Highlights Selected Australian listed companies operate across healthcare and technology sectors. These companies form part of broader ASX 200 and ASX 300 market benchmarks. Sector positioning reflects diverse operational mo...

Kalkine Media TLX 4 months ago
Focus On Telix’ Guidance Post Annus Horribilis

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin As Telix Pharmaceuticals turns the page on 2025, its annus horribilis, analysts rema...

FNArena TLX 4 months ago
3 ASX shares tipped to climb over 100% in 2026

The S&P/ASX 200 Index (ASX: XJO) closed 0.37% lower on Wednesday afternoon. For the year-to-date the index is 0.63% higher and it's 4.53% above where it was this time last year. The index hasn't posted mind-blowing gains so far this...

Motley Fool TLX 4 months ago
Top broker tips 57% upside for beaten-down Telix shares

Telix Pharmaceuticals Ltd (ASX: TLX) shares are sinking today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $11.49. During the Wednesday lunch hour, shares are chan...

Motley Fool TLX 4 months ago
Health Check: Ticker device giant backs Anteris Technologies’ hearty $430m-plus raise

 Anteris plans a US$200 million ($300 million) raising, with a “concurrent” US$90m private placement to heart device giant Medtronic Telix meets its full year guidance after a December quarter revenue surge Audeara boosts December quarter...

Stockhead TLX 4 months ago
Market Open: Wall Street’s back for WK4, and with it comes chaotic (down) day | Jan 21

ASX today − Losses are gathering steam this morning, with U.S. trading starting a day later thanks to Wall Street’s Monday holiday, and it’s sending our Australian shares towards a -0.4% open when the bell rings in Sydney. Listen to the...

themarketonline.com.au TLX 4 months ago
Telix shares in focus as the company meets guidance

Shares in Telix Pharmaceuticals Ltd (ASX: TLX) will be on watch this morning after the company late yesterday revealed it had met its full year revenue guidance and had grown its fourth quarter revenue strongly. The drug developer said i...

Motley Fool TLX 4 months ago
5 things to watch on the ASX 200 on Wednesday

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was out of form again and tumbled into the red. The benchmark index dropped 0.65% to 8,815.9 points. Will the market be able to bounce back from this on Wednesday? Here are five things to w...

Motley Fool TLX 4 months ago
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., Jan. 20, 2026 /PRNewswire/ — Telix P...

FNArena TLX 4 months ago
Why Bellevue Gold, DroneShield, Hub24, and Telix shares are storming higher today

The S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. In afternoon trade, the benchmark index is down 0.6% to 8,821 points. Four ASX shares that have not let that hold them back today are listed below. Here's why the...

Motley Fool TLX 4 months ago
Health Check: A stormy healthcare reporting season approaches, broker warns

RBC Capital Markets says pricing and other pressures are likely to lead to subdued earnings and outlook statements A wave of CEO and CFO departures is clouding the outlook Pacific Edge is confident of regaining US Medicare coverage Invest...

Stockhead TLX 4 months ago
Telix jumps on maiden Chinese application for prostate imaging agent, but short selling increasing

Telix Pharma’s (ASX:TLX) got the Chinese market locked in its sights with a maiden application for Illuccix, a prostate cancer imaging agent, now lodged with (and accepted by) the National Medical Products Application (NMPA). Worth noting i...

themarketonline.com.au TLX 4 months ago
Good news out of China has this drug company's shares higher

Shares in Telix Pharmaceuticals Ltd (ASX: TLX) are trading higher after the company announced good news out of China for its prostate cancer imaging compound, Illuccix. The company said in a statement to the ASX on Tuesday that China's...

Motley Fool TLX 4 months ago
Origin Energy to keep Eraring Power Station running until 2029

The Origin Energy Ltd (ASX: ORG) share price is in focus today after the company announced it will extend operations at the Eraring Power Station until April 2029, providing up to two more years of support for NSW's electricity grid and fur...

Motley Fool TLX 4 months ago
BHP lifts copper guidance after record half-year output

The BHP Ltd (ASX: BHP) share price is in focus today after the miner reported record copper and iron ore production for the half-year ended 31 December 2025, with copper volumes flat at 984 kt and group copper production guidance lifted for...

Motley Fool TLX 4 months ago
HUB24 posts record inflows in Q2 FY26 earnings

The HUB24 Ltd (ASX: HUB) share price is in focus today after the company reported record platform net inflows of $5.6 billion in Q2 FY26, with total Funds Under Administration (FUA) reaching $152.3 billion as at 31 December 2025, up 26% on...

Motley Fool TLX 4 months ago
Chinese NMPA Accepts New Drug Application for Illuccix for Prostate Cancer Imaging

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ — Telix Pharmac...

FNArena TLX 4 months ago
AMP appoints Blair Vernon as CEO, Alexis George to retire

The AMP Ltd (ASX: AMP) share price is in focus today after the company announced Blair Vernon will become the new Group Chief Executive Officer, with Alexis George set to retire after leading major transformation and growth since 2021. What...

Motley Fool TLX 4 months ago
Telix Pharmaceuticals receives China's nod for Illuccix prostate cancer imaging NDA

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus after the company announced the Chinese regulator has accepted the New Drug Application for Illuccix, Telix's lead imaging agent for prostate cancer. The pivotal Phase 3 study...

Motley Fool TLX 4 months ago
Northern Star Resources revises FY26 cost guidance after lower gold sales

The Northern Star Resources Ltd (ASX: NST) share price is in focus after the company revised its FY26 all-in sustaining cost (AISC) guidance to A$2,600–2,800 per ounce. The gold miner also confirmed its annual production guidance will now...

Motley Fool TLX 4 months ago
2 ASX 200 shares that could be top buys for growth

I think it could be a mistake to think that the largest S&P/ASX 200 Index (ASX: XJO) growth shares have finished expanding. For starters, there are reasons why those businesses have been as successful as they have – their product/s...

Motley Fool TLX 4 months ago
ASX 200 Weekly Pulse: Market Positioning Shifts and Sector Signals

Highlights Market positioning shifted quietly across energy, healthcare, and consumer names Resource-linked stocks reflected changing global demand signals Defensive and growth themes showed contrasting momentum Market...

Kalkine Media TLX 4 months ago
Bell Potter says these ASX shares are best buys in January

If you are on the hunt for some of the best ASX shares to buy this month, then it could pay to listen to analysts at Bell Potter. They have revealed a number of shares that they believe are best buys right now and could offer good returns i...

Motley Fool TLX 4 months ago
These are the 10 most shorted ASX shares

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Motley Fool TLX 4 months ago
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ — Telix Pharmac...

FNArena TLX 4 months ago
3 unstoppable ASX growth stocks to buy even if there's a stock market sell-off in 2026

I hope there is no stock market sell-off in 2026. Markets falling is never pleasant, and volatility can test even experienced investors. That said, whether markets rise steadily or stumble along the way, there are some ASX growth stocks...

Motley Fool TLX 4 months ago
These are the 10 most shorted ASX shares

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Motley Fool TLX 4 months ago
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ — Telix Pharmace...

FNArena TLX 4 months ago
3 phenomenal ASX stocks that could double in 2026

After a tough 2025, many investors are still licking their wounds. Several former market darlings suffered sharp selloffs as AI bubble concerns and company-specific issues weighed heavily on sentiment. But history shows that some of the str...

Motley Fool TLX 4 months ago
ASX Market Signals Reveal Stocks Facing Rising Scepticism

Highlights Bearish market positions reveal changing sentiment across key ASX names Energy, food, healthcare and education stocks remain under scrutiny Weekly disclosures offer insights into risk, valuation and market confide...

Kalkine Media TLX 4 months ago
These are the 10 most shorted ASX shares

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Motley Fool TLX 4 months ago
The ASX ‘dogs’ set to bark again in 2026

After a poor year, a slew of blue-chip stocks appears poised for a rebound With the right catalyst, share recoveries can be violent and dramatic Institutions will demand remedial action if poor performance persists Many investors prefer t...

Stockhead TLX 5 months ago
These were the worst performing ASX 200 shares in 2025

The S&P/ASX 200 Index (ASX: XJO) had a good but not exceptional year. During the 12 months, the benchmark index rose 6.8% to finish at 8,714.3 points. Unfortunately, not all shares climbed with the market. For example, the ASX 200 sha...

Motley Fool TLX 5 months ago
ASX 200 Shares Shaping Long-Term Wealth Stories in Australia

Highlights Australian-listed brands with global scale Business models built for durability Market positioning within major ASX indices Australian-listed companies with scalable retail and healthcare models highlight ho...

Kalkine Media TLX 5 months ago
2 ASX shares experts think will smash the market in 2026!

If you are looking for big returns in 2026, then read on! That's because experts believe that the ASX shares in this article have the potential to smash the market next year. Here's what they are recommending to clients for the year ahead:...

Motley Fool TLX 5 months ago
10 ASX shares I would buy in 2026

Looking ahead in 2026, I think the best investment opportunities on the ASX could come from a mix of proven compounders, long-term growth stories, and businesses that have already shown they can execute through different market conditions....

Motley Fool TLX 5 months ago
In 2036, you will be glad you bought these ASX shares today

I'm a big fan of buy and hold investing and believe it is one of the best ways to grow wealth. But which ASX shares could be worth buying and holding for the long term? Let's take a look at three that I think could be wealth generators over...

Motley Fool TLX 5 months ago
These are the 10 most shorted ASX shares

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Motley Fool TLX 5 months ago
Dr Boreham’s Crucible: 2025’s A-Z of biotechs

With the sun setting on another ‘issues rich’ year for ASX biotechs, Dr Boreham applies his stethoscope to the soaring highlights and cratering lowlights.   As usual we adopt the user-friendly A to Z format. If only drug, device and diagnos...

Stockhead TLX 5 months ago
Rudi’s View: Best Buys & Favourites For 2026

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Line up of Conviction Calls, Best Buys and most favoured sector picks for the year a...

FNArena TLX 5 months ago
2 ASX 200 shares down 30% or more that could be a new years buy

The S&P/ASX 200 Index (ASX: XJO) has had a pre-Christmas surge.  In the last 5 days, it has gained almost 3%.  This is significant when you consider it is up 7% for the entire year.  However there are a few notable ASX 200 shar...

Motley Fool TLX 5 months ago
Telix shares storm higher on big US and China news

Telix Pharmaceuticals Ltd (ASX: TLX) shares are starting the week in a positive fashion. In morning trade, the radiopharmaceuticals company's shares are up 2% to $12.25. Why are Telix shares charging higher? Investors have been buying the c...

Motley Fool TLX 5 months ago
Aurizon lodges new 10-year network access undertaking with QCA

The Aurizon Holdings Ltd (ASX: AZJ) share price could be in focus today after the rail operator announced it will lodge a proposed ten-year Network access undertaking with the Queensland Competition Authority, aiming to provide long-term ce...

Motley Fool TLX 5 months ago
These are the 10 most shorted ASX shares

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

Motley Fool TLX 5 months ago
Stockland announces estimated 1H26 distribution

The Stockland Corporation Ltd (ASX: SGP) share price is in focus today after the company declared an estimated 1H26 distribution of 9.0 cents per ordinary stapled security. The distribution will be paid on 27 February 2026 to eligible inves...

Motley Fool TLX 5 months ago
Champion Iron launches $289m Rana Gruber takeover: what shareholders need to know

The Champion Iron Ltd (ASX: CIA) share price is in focus after the company announced a cash tender offer to acquire Norwegian iron ore producer Rana Gruber for NOK 2,930 million (about US$289 million). The transaction is backed by financial...

Motley Fool TLX 5 months ago
NEXTDC lifts contracted utilisation and order book in December update

The NEXTDC Ltd (ASX: NXT) share price is in focus today after the company reported strong progress on its contracted utilisation, jumping 30% to reach 412MW following new customer wins. NEXTDC's pro-forma forward order book also grew signif...

Motley Fool TLX 5 months ago
Telix Pharmaceuticals in focus with China trial success and FDA updates

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company released an update on its precision medicine portfolio, highlighting positive Phase 3 results for Illuccix in China and progress on key FDA regulatory...

Motley Fool TLX 5 months ago
Monadelphous wins $250m Rio Tinto contract: What it means for shareholders

The Monadelphous Group Ltd (ASX: MND) share price is in focus after the engineering company announced a major $250 million construction contract with Rio Tinto Ltd (ASX: RIO) for the Brockman Syncline 1 iron ore development. The project wil...

Motley Fool TLX 5 months ago